In vitro evaluation of the physicochemical effects of drug loaded carbon nanotubes on toxicity

Journal of Nanomedicine and Nanotechnology

Volumn 3, Issue 4, 2012, Pages

  Chigumbu, Nyaradzo ^a   Iyuke, Sunny ^a   Pillay, Viness ^b   Ndlovu, Sehliselo ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Carbon nanotubes; Drug delivery; Functionalization; Toxicity

Indexed keywords

EID: 84878080728     PISSN: None     EISSN: 21577439     Source Type: Journal    
DOI: 10.4172/2157-7439.1000135     Document Type: Article

References (29)

1. Thostenson ET, Ren Z, Chou TW (2001) Advances in the science and technology of carbon nanotubes and their composites: A review. Compos Sci Technol 61: 1899-1912.
2. Jorio A, Saito R, Hafner JH, Lieber CM, Hunter M, et al. (2001) Structural (n, m) determination of isolated single-wall carbon nanotubes by resonant Raman scattering. Phys Rev Lett 86: 1118-1121.
3. Peigney A, Laurent Ch, Flahaut E, Bacsa RR, Rousset A (2001) Specific surface area of carbon nanotubes and bundles of carbon nanotubes. Carbon 39: 507-514.
4. Hughes JT (1982) Pathology of amyotrophic lateral sclerosis. Adv Neurol 36: 61-74.
5. Williams DB, Windebank AJ (1991) Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin Proc 66: 54-82.
6. Kurtzke JF (1982) Epidemiology of amyotrophic lateral sclerosis. Adv Neurol 36: 281-302.
7. Schepelmann K, Winter Y, Spottke AE, Claus D, Grothe C, et al. (2010) Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257: 15-23.
8. Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330: 585-591.
9. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) An outcome study of riluzole in amyotrophic lateral sclerosis: A population-based study in Ireland, 1996-2000. J Neurol 250: 473-479.
10. Allen TM, Cullis PR (2004) Drug Delivery Systems: Entering the Mainstream. Science 303: 1818-1822.
11. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr opin chem biol 9: 674-679.
12. Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, et al. (2005) Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl 44: 6358-6362.
13. Kang S, Mauter MS, Elimelech M (2008) Physicochemical determinants of multiwalled carbon nanotube bacterial cytotoxicity. Environ Sci Technol 42: 7528-7534.
14. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, et al. (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3: 423-428.
15. Hirano S, Kanno S, Furuyama A (2008) Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 232: 244-251.
16. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H (2006) Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol in Vitro 20: 1202-1212.
17. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, et al. (2006) Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161: 135-142.
18. Dumortier H, Lacotte S, Pastorin G, Marega R, Wu W, et al. (2006) Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano lett 6: 1522-1528.
19. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, et al. (2003) Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 66: 1909-1926.
20. Pulskamp K, Diabate S, Krug HF (2007) Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168: 58-74.
21. Powers KW, Palazuelos M, Moudgil BM, Roberts SM (2007) Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicol 1: 42-51.
22. Pastorin G, Wu W, Wieckowski S, Briand JP, Kostarelos K, et al. (2006) Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun: 1182-1184.
23. Iyuke SE, Abdulkareem SA, Afolabi SA, Piennar CHV (2007) Catalytic production of carbon nanotubes in a swirled fluid chemical vapour deposition reactor. International Journal of Chemical Reactor Engineering 5.
24. Li Y, Zhang X, Luo J, Huang W, Cheng J, et al. (2004) Purification of CVD synthesized single-wall carbon nanotubes by different acid oxidation treatments. Nanotechnol 15: 1645-1649.
25. Chen JP, Lin M (2001) Surface charge and metal ion adsorption on an H-type activated carbon: Experimental observation and modeling simulation by the surface complex formation approach. Carbon 39: 1491-1504.
26. Ramesh BP, Blau WJ, Tyagi PK, Misra DS, Ali N, et al. (2006) Thermogravimetric analysis of cobalt-filled carbon nanotubes deposited by chemical vapour deposition. Thin Solid Films 494: 128-132.
27. Kim JS, Song KS, Joo HJ, Lee JH, Yu IJ (2010) Determination of cytotoxicity attributed to multiwall carbon nanotubes (MWCNT) in normal human embryonic lung cell (WI-38) line. J Toxicol Environ Health A: Current Issues 73: 1521-1529.
28. Sato Y, Yokoyama A, Shibata KI, Akimoto Y, Ogino S, et al. (2005) Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol Biosyst 1: 176-182.
29. Azbill RD, Mu X, Springer JE (2000) Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain res 871: 175-180.